Neoadjuvant Anti-PD-L1/Chemo Combo Shows Promise in Resectable NSCLC

(MedPage Today) — Study Authors: Catherine A. Shu, Justin F. Gainor, et al.; Rafael Rosell, Masaoki Ito
Target Audience and Goal Statement: Oncologists, pulmonologists
The goal of this study was to determine the benefit/risk profile of neoadjuvant…
Read More

Leave a Reply

%d bloggers like this: